CLOs on the Move

FanAI

www.fan.ai

 
FanAI is a sponsorship marketplace that helps rights holders monetize their fans and brands optimize their sponsorship spend. FanAI delivers actionable audience insights and offline attribution to drive improved sponsorship outcomes.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.fan.ai
  • 1411 5th Street Suite 202
    Santa Monica, CA USA 90401
  • Phone: n/a

Executives

Name Title Contact Details

Similar Companies

Entercoms

Entercoms drives real-world results in aftermarket operations. Since 2008, market-leading clients including GE, Dell, Oracle, and Motorola have engaged Entercoms for unrivaled expertise in designing and managing increasingly complex aftermarket and service supply chains operations.   As knowledgeable partners and strategic allies for global operations leaders, Entercoms’ time-tested tools, human intelligence and actionable operating analytics improve both customer experience and the bottom line – without one jeopardizing the other.

Digisoft Computers Inc

Digisoft Computers Inc is a New York, NY-based company in the Software and Internet sector.

Dovetail Software

Dovetail Software is a Austin, TX-based company in the Software and Internet sector.

Jvion

Jvion helps healthcare organizations identify, assess and change the course of avoidable health and financial risks. Using prescriptive clinical artificial intelligence, Jvion is able to identify specific patients on a risk trajectory, determine if that trajectory can be changed, and if so, recommends patient-specific interventions.

Cypher Genomics

Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.